GlassScriptPhysician profile
Elizabeth Keeter
NPI 1366882078
$416.27
in general payments reported to CMS, 2019-2025
11 companies · $86.80 in 2025
The $86.80 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $95.77 · 2022: $128 · 2023: $53.36 · 2024: $52.76 · 2025: $86.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $192.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $83.38 | 2021-2022 | |
| Exeltis, USA INC. | $82.82 | 2021-2025 | Slynd |
| Evofem Biosciences, INC. | $59.94 | 2021-2023 | Phexxi |
| Organon LLC | $50.29 | 2023-2025 | Nexplanon, Jada System |
| Hologic Sales and Service, LLC | $32.86 | 2025 | Aptima |
| Abbvie INC. | $28.10 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.71 | 2024 | |
| Pfizer INC. | $15.33 | 2024 | |
| Therapeuticsmd, INC. | $14.77 | 2021 | |
| Merck Sharp & Dohme LLC | $13.55 | 2022 | |
| Avion Pharmaceuticals | $11.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Keeter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.